ABBOTT LABORATORIES (1ABT.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1ABT - US0028241000 - Common Stock
1ABT.MI Key Statistics, Chart & Performance
The current stock price of 1ABT.MI is 106.36 EUR.
1ABT.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.78 | 109.21B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.37 | 52.23B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.7 | 23.79B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.52 | 23.54B | ||
| BIM.PA | BIOMERIEUX | 29.47 | 13.46B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 148.88 | 4.48B | ||
| DIA.MI | DIASORIN SPA | 21.76 | 4.03B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.66 | 3.84B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.17 | 1.35B | ||
| ELN.MI | EL.EN. SPA | 22.55 | 1.16B | ||
| DRW8.DE | DRAEGERWERK AG | 9.13 | 1.10B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 24.05 | 992.82M |
Related stock screener links
About 1ABT.MI
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS US
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / 1ABT.MI FAQ
What does 1ABT do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
What is the current price of 1ABT stock?
The current stock price of 1ABT.MI is 106.36 EUR. The price decreased by -1.35% in the last trading session.
What is the dividend status of ABBOTT LABORATORIES?
ABBOTT LABORATORIES (1ABT.MI) has a dividend yield of 2.02%. The yearly dividend amount is currently 1.88.
What is the ChartMill technical and fundamental rating of 1ABT stock?
1ABT.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is ABBOTT LABORATORIES (1ABT.MI) stock traded?
1ABT.MI stock is listed on the Euronext Milan exchange.
How is the valuation of ABBOTT LABORATORIES (1ABT.MI) based on its PE ratio?
The PE ratio for ABBOTT LABORATORIES (1ABT.MI) is 25.03. This is based on the reported non-GAAP earnings per share of 4.25 and the current share price of 106.36 EUR.
1ABT.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1ABT.MI.
1ABT.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1ABT.MI. 1ABT.MI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
1ABT.MI Financial Highlights
Over the last trailing twelve months 1ABT.MI reported a non-GAAP Earnings per Share(EPS) of 4.25. The EPS increased by 10.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.88% | ||
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| Debt/Equity | 0.23 |
1ABT.MI Forecast & Estimates
35 analysts have analysed 1ABT.MI and the average price target is 126.5 EUR. This implies a price increase of 18.94% is expected in the next year compared to the current price of 106.36.
For the next year, analysts expect an EPS growth of 11.44% and a revenue growth 6.44% for 1ABT.MI